On May 16, 2025, Medpace Holdings, Inc. held its Annual Meeting, where stockholders approved the Amended 2016 Incentive Award Plan, extending the expiration date to February 6, 2035, without increasing share authorization. Various proposals, including director elections and the appointment of Deloitte as auditors, received favorable votes.